The new TRANSCAN-3 project consortium has launched the first Joint Transnational Call for proposals, co-funded by the European Commission,
"Next generation cancer immunotherapy: targeting the tumour microenvironment"
go to the call webpage

International Networking Event (virtual)

on 22 April 2021 hrs 9:00 CET

it will focus on the forthcoming co-funded Joint Transnational Call for proposals on:
"Next generation cancer immunotherapy: targeting the tumour microenvironment" 

the event is organized by TUBITAK under the “Turkey in Horizon 2020 Phase II” Technical Assistance Project
in cooperation with TRANSCAN-3


Participants will have to opportunity to get first-hand information about TRANSCAN-3 and JTC2021, present their project ideas and have online face to face meetings to network.

Participants can register up until 21 April.
Participants who want to have a pitch presentation can upload their presentations (using the template) until 15 April.
Participants can book their face to face meetings from 5 April to 21 April.

 A TRANSCAN-2 brochure, highlighting key achievements, is available for download.

The 3rd and final TRANSCAN-2 symposium on Tumour Heterogeneity was held in Milan on October 24th, 2019

The symposium included talks from the funded consortia of JTC2014 co-funded by the EU, an exciting discussion on the impact and added value of transnational collaborations on cancer research and a poster prize competition for young scientists.
The event was hosted by Regione Lombardia, Italy, with the collaboration of Fondazione Regionale per la Ricerca Biomedica

Abstract book
For further information please contact: This email address is being protected from spambots. You need JavaScript enabled to view it.



JTC 2017 on: Translational research on rare cancers

12 projects selected for funding, visit the page


JTC 2016 on: Minimally and non-invasive methods for early detection and/or progression of cancer.

14 projects selected for funding


JTC 2015 on: Immunology and immunotherapy of cancer: strengthening the translational aspects.

7 projects selected for funding

JTC 2014 on: Translational research on human tumour heterogeneity to overcome recurrence and resistance to therapy.

16 projects selected for funding